| payload |
{"created_at":"2026-04-10T03:04:31.796 {"created_at":"2026-04-10T03:04:31.796915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:2835702ae7ed5f66","evidence_event_ids":["evt_9e10494a463a"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt","company":"Whitehawk Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt","article_chars":2782,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_6546e2d67764ba4d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:14:40.310011+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt","source_event_id":"evt_9e10494a463a","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"f6f230ab8bf1d32c","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-09","2026-04-01","2026-04-02","2026-04-06","2026-04-07","2026-04-08","2026-04-09","2026-03-02","2021-08-26","2017-03-16","2007-12-27"],"entities":[{"asset_class":"equity","name":"Whitehawk Therapeutics, Inc.","relevance":"high","symbol":"WHWK","type":"issuer"},{"asset_class":"equity","name":"Lennon David James","relevance":"high","symbol":"","type":"reporting-owner_officer_director"},{"asset_class":"equity","name":"E-TRADE Financial Corporation","relevance":"medium","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The filing\u2019s full Form 144 table details (e.g., total shares, aggregate sale amount, whether sales are pursuant to Rule 144 volume limits) are not fully enumerated in the provided cleaned text.","What changed vs a prior known state is not provided in the signal; only the existence of this Form 144 filing is shown.","No explicit \u201cprevious filing\u201d reference or comparison fields are included, so delta magnitude cannot be determined from the provided text."],"key_facts":["SEC accession number: 0001995275-26-000011.","Form type: 144.","Filed as of date: 2026-04-09; date of change: 2026-04-09.","Subject company/issuer: Whitehawk Therapeutics, Inc. (CIK 0001422142).","Reporting owner: Lennon David James (CIK 0001995275), listed as Officer/Director.","Security: Common Stock; exchange indicated as NASDAQ.","The filing includes multiple sale entries with different \u201cdate of sale\u201d values in early April 2026 (03/02/2026, 04/01/2026, 04/02/2026, 04/06/2026, 04/07/2026, 04/08/2026, 04/09/2026).","One stated purpose: \u201cShares to be sold to cover withholding taxes upon vesting of restricted stock unit award.\u201d","Signature: /s/ Stephen Rodin, as Attorney-in-Fact."],"numeric_claims":[{"label":"Sale price per share (example entry)","value":"14750.32 / 4364 shares (implied by listed numbers)"},{"label":"Shares to be sold (example entry)","value":"775828 (listed alongside 04/01/2026 entry)"},{"label":"Shares to be sold (example entry)","value":"5100 (listed alongside 03/02/2026 entry)"},{"label":"Shares to be sold (example entry)","value":"102395 (listed alongside 04/06/2026 entry)"}],"primary_claim":"On 2026-04-09, Whitehawk Therapeutics, Inc. filed SEC Form 144 (accession 0001995275-26-000011) for the sale of its common stock by Lennon David James.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Whitehawk Therapeutics, Inc. filed a Form 144 on 2026-04-09. The filing relates to sales of common stock by officer/director Lennon David James, including shares to cover withholding taxes upon vesting of restricted stock units.","topics":["SEC Form 144","insider/officer sale","restricted stock units","common stock","withholding taxes"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Whitehawk Therapeutics, Inc. \u00b7 Filed 20260409","ticker":"WHWK","tickers":["WHWK"],"title":"WHWK filed 144","url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000011.txt"}}... |